Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 11, 2012, Pages 1681-1687

  Lo, Gin Ho ^a   Chen, Wen Chi ^a   Wang, Huay Min ^a   Yu, Hsien Chung ^a  

^a I SHOU UNIVERSITY   (Taiwan)

Author keywords

Beta blocker; Carvedilol; Nitrovasodilator; Variceal rebleeding

Indexed keywords

BILIRUBIN; CARVEDILOL; ISOSORBIDE MONONITRATE; NADOLOL; SERUM ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; ASTHMA; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; HUMAN; IMPOTENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; STOMACH VARICES; SURVIVAL; UPPER GASTROINTESTINAL BLEEDING; UPPER GASTROINTESTINAL TRACT;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARBAZOLES; CHI-SQUARE DISTRIBUTION; DRUG THERAPY, COMBINATION; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, ENDOSCOPIC; HUMANS; HYPERTENSION, PORTAL; ISOSORBIDE DINITRATE; KAPLAN-MEIER ESTIMATE; LIGATION; MALE; MIDDLE AGED; NADOLOL; PROPANOLAMINES; PROPORTIONAL HAZARDS MODELS; RECURRENCE; VASODILATOR AGENTS;

EID: 84868156470     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2012.07244.x     Document Type: Article

References (32)

1. Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet 2003; 361: 952-954.
2. Loh GH. Prevention of esophageal variceal rebleeding. J. Chin. Med. Assoc. 2006; 69: 553-560.
3. Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N. Engl. J. Med. 2010; 362: 823-832.
4. Laine L. Ligation: endoscopic treatment of choice for patients with bleeding esophageal varices? Hepatology 1995; 22: 663-665.
5. Lo GH, Lai KH, Cheng JS etal. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology 1995; 22: 466-471.
6. Lebrec D, Poynard T, Hillon P, Benhamou J-P. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study. N. Engl. Med. 1981; 305: 1371-1374.
7. Garcia-Pagan JC, Navasa M, Bosch J, Bru C, Pizcueta P, Rodes J. Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis. Hepatology 1990; 11: 230-238.
8. Gournay J, Masliah C, Martin T, Perrin D, Galmiche JP. Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding. Hepatology 2000; 31: 1239-1245.
9. Villanueva C, Minyana J, Ortiz J etal. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal rebleeding. N. Engl. J. Med. 2001; 345: 647-655.
10. Banares R, Moitinho E, Matilla A etal. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. Hepatology 2002; 36: 1367-1373.
11. Tripathi D, Therapondos G, Lui HF, Stanley AJ, Hayes PC. Hemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating β-blocker, in patients with cirrhosis and portal hypertension. Aliment. Pharmacol. Ther. 2002; 16: 373-380.
12. Lo GH, Lai KH, Cheng JS etal. Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices. Hepatology 1997; 25: 1101-1104.
13. Pugh RNN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of esophagus for bleeding esophageal varices. Br. J. Surg. 1973; 60: 646-649.
14. Beppu K, Inokuchi K, Koyanagi N etal. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest. Endosc. 1981; 27: 213-218.
15. Sarin SK, Primignani M, Agarwal SR. Gastric varices. In: de Franchis R, ed. Portal Hypertension III. Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Oxford: Blackwell, Science, 2001; 76-96.
16. Groszmann RJ, Garcia-Tsao G, Bosch J etal. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N. Engl. J. Med. 2005; 353: 2254-2261.
17. Burroughs AK, Cales P, Kravetz D etal. Definition of key events-last attempt? In: de Franchis R, ed. Portal Hypertension. Proceedings of the Fourth Baveno International Consensus Workshop on Methodology of Diagnosis and Treatment. Oxford: Blackwell Science, 2006; 11-39.
18. Lo GH, Lai KH, Cheng JS, Chen MH, Chiang HT. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 2001; 33: 1060-1064.
19. Bernard-Chabert B, Sauerbruch T, Lo GH etal. Prevention of rebleeding. In: de Franchis R, ed. Portal Hypertension. Proceedings of the Fourth Baveno International Consensus Workshop on Methodology of Diagnosis and Treatment. Oxford: Blackwell Science, 2006; 262-284.
20. Lo GH, Lai KH, Cheng JS etal. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology 2000; 32: 461-465.
21. Garcia-Pagan JC, Villaneuva C, Albillos A etal. Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicenter randomized controlled trial. Gut 2009; 58: 1144-1150.
22. Lo GH, Chen WC, Chen MH, Lai KH. A randomized, controlled trial of banding ligation plus drug therapy vs drug therapy alone in the prevention of esophageal variceal rebleeding. J. Gastroenterol. Hepatol. 2009; 24: 982-987.
23. Lo GH, Chen WC, Lin CK etal. Improved survival in patients receiving medical therapy as compared with banding ligation for the prevention of esophageal variceal rebleeding. Hepatology 2008; 48: 580-587.
24. Hernandez-Gea V, Aracil C, Villanueva C. Management of varices in cirrhosis (Letter). N. Engl. J. Med. 2010; 362: 2332-2333.
25. Loh GH. Management of varices in cirrhosis (letter). N. Engl. J. Med. 2010; 362: 2332.
26. Cheung J, Zeman M, Zanten SVV, Tandon P. Systematic review: secondary prevention with band ligation, pharmacotherapy or combination therapy after bleeding from esophageal varices. Aliment. Pharmacol. Ther. 2009; 30: 577-588.
27. Bosch J. Cardevilol for portal hypertension in patients with cirrhosis. Hepatology 2010; 51: 2214-2218.
28. Banares R, Moitinho E, Piqueras B etal. Carvedilol, a new nonselective beta-blocker with intrinsic anti-alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. Hepatology 1999; 30: 79-83.
29. Lin HC, Yang YY, Hou MC, Huang YT, Lee FY, Lee SD. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis. Am. J. Gastroenterol. 2004; 99: 1953-1958.
30. Tripathi D, Ferguson JW, Kochar N etal. Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology 2009; 50: 825-833.
31. Lo GH, Chen WC, Chen MH etal. A prospective, randomized trial of endoscopic variceal ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding. Gastroenterology 2002; 123: 728-734.
32. Patch D, Sabin CA, Goulis J etal. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 2002; 123: 1013-1019.